Table 3. Mild, moderate, and severe state anxiety and depression scores before and after the intervention in both groups, first and second treatment periods.
| Groups | First period | Second period | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Before intervention | After intervention | Before intervention | After intervention | |||||||||
| Mild | Moderate | Severe | Mild | Moderate | Severe | Mild | Moderate | Severe | Mild | Moderate | Severe | |
| State anxiety | ||||||||||||
| A* | 2 (10.5) | 14 (73.7) |
3 (15.8) | 15 (78.9) |
4 (21.1) |
- | 10 (58.8) | 7 (41.2) |
- | 11 (64.7) | 6 (35.3) |
- |
| B | 1 (5.0) | 18 (90.0) |
1 (5.0) | 8 (40.0) |
12 (60.0) |
- | 6 (30.0) | 14 (70.0) |
- | 13 (65.0) | 7 (35.0) |
- |
| Depression | ||||||||||||
| A* | 4 (33.3) | 8 (66.7) |
- | 5 (100) |
- | - | 4 (80.0) | 1 (20.0) |
- | 4 (80.0) | 1 (20.0) |
- |
| B | 7 (58.3) | 5 (41.7) |
- | 8 (72.7) |
3 (27.3) |
- | 12 (80.0) | 3 (20.0) |
- | 5 (100) |
- | - |
*Group A took valerian capsules in the first month and placebo in the second month, and vice versa in group B.
Data were given as n (%).